Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Josefina Marin, María Laura Acosta Felquer, Enrique R Soriano Rheumatology Unit, Internal Medical Serivces, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Abstract: Certolizumab pegol (CZP) is a pegylated huma...

Full description

Bibliographic Details
Main Authors: Marin J, Acosta Felquer ML, Soriano ER
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Open Access Rheumatology : Research and Reviews
Subjects:
certolizumab pegol
tumor necrosis factor-α inhibitors
ankylosing spondilitys
non-radiographic axial spondyloarthritis
efficacy
safety
Online Access:https://www.dovepress.com/spotlight-on-certolizumab-pegol-in-the-treatment-of-axial-spondyloarth-peer-reviewed-article-OARRR

Internet

https://www.dovepress.com/spotlight-on-certolizumab-pegol-in-the-treatment-of-axial-spondyloarth-peer-reviewed-article-OARRR

Similar Items